These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8267795)
21. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Rofstad EK; Mathiesen B; Kindem K; Galappathi K Cancer Res; 2006 Jul; 66(13):6699-707. PubMed ID: 16818644 [TBL] [Abstract][Full Text] [Related]
22. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression. Carl VS; Gautam JK; Comeau LD; Smith MF J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058 [TBL] [Abstract][Full Text] [Related]
23. Involvement of growth-related protein in lipopolysaccharide-induced rabbit arthritis: cooperation between growth-related protein and IL-8, and interrelated regulation among TNFalpha, IL-1, IL-1 receptor antagonist, IL-8, and growth-related protein. Matsukawa A; Yoshimura T; Fujiwara K; Maeda T; Ohkawara S; Yoshinaga M Lab Invest; 1999 May; 79(5):591-600. PubMed ID: 10334570 [TBL] [Abstract][Full Text] [Related]
24. The interleukin-1 receptor antagonist and its delivery by gene transfer. Evans CH; Robbins PD Receptor; 1994; 4(1):9-15. PubMed ID: 8038709 [TBL] [Abstract][Full Text] [Related]
25. Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver. Mendoza L; Olaso E; Anasagasti MJ; Fuentes AM; Vidal-Vanaclocha F J Cell Physiol; 1998 Mar; 174(3):322-30. PubMed ID: 9462694 [TBL] [Abstract][Full Text] [Related]
26. Interleukin 1 receptor antagonist localization exclusively in non-parenchymal cells of the mouse liver. Rokita H; Kosz-Vnenchak M; Stalińska K; Stachura J Cytokine; 1997 Apr; 9(4):249-53. PubMed ID: 9112333 [TBL] [Abstract][Full Text] [Related]
27. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. Vidal-Vanaclocha F; Alvarez A; Asumendi A; Urcelay B; Tonino P; Dinarello CA J Natl Cancer Inst; 1996 Feb; 88(3-4):198-205. PubMed ID: 8632494 [TBL] [Abstract][Full Text] [Related]
28. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer. Gouze JN; Gouze E; Palmer GD; Liew VS; Pascher A; Betz OB; Thornhill TS; Evans CH; Grodzinsky AJ; Ghivizzani SC Arthritis Res Ther; 2003; 5(5):R301-9. PubMed ID: 12932294 [TBL] [Abstract][Full Text] [Related]
29. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation. Yamada J; Zhu SN; Streilein JW; Dana MR Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616 [TBL] [Abstract][Full Text] [Related]
31. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Langley RR; Carlisle R; Ma L; Specian RD; Gerritsen ME; Granger DN Microcirculation; 2001 Oct; 8(5):335-45. PubMed ID: 11687945 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Bargetzi MJ; Lantz M; Smith CG; Torti FM; Olsson I; Eisenberg SP; Starnes HF Cancer Res; 1993 Sep; 53(17):4010-3. PubMed ID: 8395334 [TBL] [Abstract][Full Text] [Related]
33. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282 [TBL] [Abstract][Full Text] [Related]
34. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia. Calkins CM; Bensard DD; Shames BD; Pulido EJ; Abraham E; Fernandez N; Meng X; Dinarello CA; McIntyre RC J Endotoxin Res; 2002; 8(1):59-67. PubMed ID: 11981446 [TBL] [Abstract][Full Text] [Related]
35. CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice. Kotani M; Hirata K; Ogawa S; Habiro K; Ishida Y; Tanuma S; Horai R; Iwakura Y; Kishimoto H; Abe R Arthritis Rheum; 2006 Feb; 54(2):473-81. PubMed ID: 16453283 [TBL] [Abstract][Full Text] [Related]
36. IL-10 and IL-4 synergize with TNF-alpha to induce IL-1ra production by human neutrophils. Marie C; Pitton C; Fitting C; Cavaillon JM Cytokine; 1996 Feb; 8(2):147-51. PubMed ID: 8777273 [TBL] [Abstract][Full Text] [Related]
37. Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel. Guénard V; Dinarello CA; Weston PJ; Aebischer P J Neurosci Res; 1991 Jul; 29(3):396-400. PubMed ID: 1833560 [TBL] [Abstract][Full Text] [Related]
39. Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist. Kim JM; Jeong JG; Ho SH; Hahn W; Park EJ; Kim S; Yu SS; Lee YW; Kim S Gene Ther; 2003 Sep; 10(18):1543-50. PubMed ID: 12907945 [TBL] [Abstract][Full Text] [Related]
40. The in vivo effect of recombinant human interleukin-1 receptor antagonist on spleen colony forming cells after radiation induced myelosuppression. Milenkovíc P; Ivanovíc Z; Stosić-Grujicić S Eur Cytokine Netw; 1995; 6(3):177-80. PubMed ID: 8589274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]